A Study of the Donor Screening Experience and the Outcomes from Fecal Transplant in Patients with C. Difficile Infection


About this study

The purpose of this study is to evaluate clinical experience with donor screening for fecal transplant, and to evaluate the outcomes from fecal transplant and understand risk factors for fecal transplant failure and relapse after fecal transplant.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Group 1,  Healthy individuals who have been screened as stool donors
  • Group 2,  Patients who have received fecal transplantation for C. difficile infection

Exclusion Criteria 

  • Pediatric patients 
  • Healthy individuals who have not been screened as stool donors 
  • Patients who have not undergone fecal transplant



Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Robert Orenstein, D.O.

Closed for enrollment

Contact information:

Robert Orenstein D.O.

(480) 342-0115


Rochester, Minn.

Mayo Clinic principal investigator

Sahil Khanna, M.B.B.S.

Closed for enrollment

Contact information:

Patricia Kammer CCRP

(507) 538-1827


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer